Urinary tract infection in pregnancy

Vários fatores tornam a infecção do trato urinário (ITU) uma relevante complicação do período gestacional, agravando tanto o prognóstico materno quanto o prognóstico perinatal. Durante muitos anos, a gravidez foi vista como fator predisponente a todas as formas de ITU. Hoje, sabe-se que ela, como evento isolado, não é responsável por maior incidência de ITU; as mudanças anatômicas e fisiológicas impostas ao trato urinário pela gravidez predispõem à transformação de mulheres bacteriúricas assintomáticas (BA) em gestantes com ITU sintomáticas. A BA acomete entre 2 e 10% de todas as gestantes, das quais aproximadamente 30% desenvolverão pielonefrite, se não tratadas adequadamente. No entanto, observa-se incompreensível resistência dos pré-natalistas à identificação da BA neste período. Seu diagnóstico é microbiológico e baseia-se em duas uroculturas apresentando mais que 10(5) colônias/mL de urina, identificando-se o mesmo germe. Seu tratamento é facilitado, visto que pode ser baseado no antibiograma, não havendo fundamentação científica de que o pré-estabelecimento de esquemas terapêuticos seja uma medida adequada. Para o tratamento da pielonefrite, não é possível aguardar o resultado da cultura e o conhecimento prévio do perfil de resistência dos antibacterianos disponíveis para uso em gestantes seria a melhor medida. Outra variável importante é utilizar um antibiótico bactericida, endovenoso na fase aguda da infecção e com possibilidades de ser administrado via oral após a melhora clínica da paciente, em seu domicílio. Em nosso meio, a droga que melhor atende a todas estas demandas é a cefuroxima, utilizada por um período de 10-14 dias. As cefalosporinas de terceira geração não existem na forma oral, carreando o inconveniente de tratamento parenteral em sua totalidade. Em decorrência dos efeitos colaterais, considera-se inadequado o uso de aminoglicosídeos em gestantes. Apesar das inconsistentes insinuações de contra-indicações das quinolonas monofluoradas, havendo indicação, acredita-se que a norfloxacina possa ser uma boa opção à cefuroxima. Para os casos em que a profilaxia da ITU está indicada, preferem-se os quimioterápicos, entre eles a nitrofurantoína, com o cuidado de evitar seu uso no final da gravidez pelo risco de kernicterus no neonato.Several factors cause urinary tract infection (UTI) to be a relevant complication of the gestational period, aggravating both the maternal and perinatal prognosis. For many years, pregnancy has been considered to be a factor predisposing to all forms of UTI. Today, it is known that pregnancy, as an isolated event, is not responsible for a higher incidence of UTI, but that the anatomical and physiological changes imposed on the urinary tract by pregnancy predispose women with asymptomatic bacteriuria (AB) to become pregnant women with symptomatic UTI. AB affects 2 to 10% of all pregnant women and approximately 30% of these will develop pyelonephritis if not properly treated. However, a difficult to understand resistance against the identification of AB during this period is observed among prenatalists. The diagnosis of UTI is microbiological and it is based on two urine cultures presenting more than 10(5) colonies/mL urine of the same germ. Treatment is facilitated by the fact that it is based on an antibiogram, with no scientific foundation for the notion that a pre-established therapeutic scheme is an adequate measure. For the treatment of pyelonephritis, it is not possible to wait for the result of culture and previous knowledge of the resistance profile of the antibacterial agents available for the treatment of pregnant women would be the best measure. Another important variable is the use of an intravenous bactericidal antibiotic during the acute phase, with the possibility of oral administration at home after clinical improvement of the patient. At our hospital, the drug that best satisfies all of these requirements is cefuroxime, administered for 10-14 days. Third-generation cephalosporins do not exist in the oral form, all of them involving the inconvenience of parenteral administration. In view of their side effects, aminoglycosides are considered to be inadequate for administration to pregnant women. The inconsistent insinuation of contraindication of monofluorinated quinolones, if there is an indication, norfloxacin is believed to be a good alternative to cefuroxime. In cases in which UTI prophylaxis is indicated, chemotherapeutic agents are preferred, among them nitrofurantoin, with care taken to avoid its use at the end of pregnancy due to the risk of kernicterus for the neonate

Effect of carbamide peroxide-based bleaching agents containing fluoride or calcium on tensile strength of human enamel

OBJECTIVE: The aim of this study was to evaluate the effects of carbamide peroxide-based bleaching agents (CPG) containing fluoride (CF) or calcium (CCa) on the ultimate tensile strength of enamel (UTS). METHOD: A "cube-like" resin composite structure was built-up on the occlusal surface of twenty-two sound third molars to facilitate specimen preparation for the micro-tensile test. The restored teeth were serially sectioned in buccal-lingual direction in slices with approximate 0.7 mm thickness. Each slice was trimmed with a fine diamond bur to reduce the buccal, internal slope enamel of the cusps to a dumb-bell shape with a cross-sectional area at the "neck" of less than 0.5 mm². The samples were randomly divided into 12 groups (n=11). The control groups were not submitted to the bleaching regimen. Specimens were treated with 10% CPG gel or with 10% CPG formulations containing CF (0.2% and 0.5%) or CCa (0.05% and 0.2%). Bleached groups received the application of the 10% CPGs for 6 hours/day at 37º C, during 14 consecutive days and were stored in artificial saliva (AS) or 100% relative humidity (RH) among each application. After bleaching, specimens were tested with the microtensile method at 0.5 mm/min. Data were analyzed by two-way ANOVA and Tukey test (5%). RESULTS: No significant difference was observed between groups stored in AS or RH. Specimens treated with CF or CCa presented similar UTS as unbleached control groups. CONCLUSION: Either 10% CPG formulations containing CF or CCa can preserve the UTS after bleaching regimen.OBJETIVO: O propósito deste estudo foi avaliar os efeitos de agents clareadores à base de peróxido de carbamida (CPG) contendo fluoreto (CF) e cálcio (CCa) na resistência à tração do esmalte (UTS). MÉTODO: Um bloco de resina composta foi confeccionada na superfície oclusal de vinte e dois terceiros molars hígidos para facilitar a preparação dos espécimes para o teste de micro-tração. Os dentes restaurados foram seccionados com disco diamantado no sentido vestíbulo-lingual em fatias de aproximadamente 0,7 mm de espessura. Com uma ponta diamantada, foi realizada uma constrição na região de esmalte da vertente oclusal interna. Os espécimes apresentaram aproximadamente 0,5 mm² de área na secção transversal da região de constrição e foram divididos em 12 grupos (n=11). Os grupos controles não foram submetidos ao regime clareador e os experimentais foram tratados com gel de CPG 10% ou com formulações de CPG 10% contendo CF (0,2% e 0,5%) ou CCa (0,05% e 0,2%). Os grupos clareadores receberam a aplicação dos CPGs por 6 horas/dia a 37ºC, durante 14 dias consecutivos e foram armazenados em saliva artificial (AS) ou em umidade relativa 100% (RH), entre as aplicações do gel clareador. Após o clareamento, os espécimes foram testados através do método de micro-tração (0,5 mm/min). Os dados foram analisados pela ANOVA (2 fatores) e teste Tukey (5%). RESULTADOS: Nenhuma diferença foi observada entre os grupos armazenados em AS ou RH. Os espécimes tratados com CPG com CF ou Cca apresentaram similar UTS aos grupos controles não clareados. CONCLUSÃO: Ambos CPGs 10% CF or CCa não alteraram a UTS após o tratamento clareador

Enamel susceptibility to red wine staining after 35% hydrogen peroxide bleaching

Concern has been expressed regarding the staining of enamel surface by different beverages after bleaching. This study investigated the influence of 35% hydrogen peroxide bleaching agents on enamel surface stained with wine after whitening treatments. Flat and polished bovine enamel surfaces were submitted to two commercially available 35% hydrogen peroxide bleaching agents or kept in 100% humidity, as a control group (n = 10). Specimens of all groups were immersed in red wine for 48 h at 37°C, immediately, 24 h or 1 week after treatments. All specimens were ground into powder and prepared for the spectrophotometric analysis. Data were subjected to two-way analysis of variance and Fisher's PLSD test at 5% significance level. The amount of wine pigments uptake by enamel submitted to bleaching treatments was statistically higher than that of control group, independently of the evaluation time. Results suggested that wine staining susceptibility was increased by bleaching treatments

Therapeutic alternatives in chronic thromboembolic pulmonary hypertension: from pulmonary endarterectomy to balloon pulmonary angioplasty to medical therapy. State of the art from a multidisciplinary team

Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare disease with a very complex pathophysiology differing from other causes of pulmonary hypertension (PH). It is an infrequent consequence of acute pulmonary embolism that is frequently misdiagnosed. Pathogenesis has been related to coagulation abnormalities, infection or inflammation, although these disturbances can be absent in many cases. The hallmarks of CTEPH are thrombotic occlusion of pulmonary vessels, variable degree of ventricular dysfunction and secondary microvascular arteriopathy. The definition of CTEPH also includes an increase in mean pulmonary arterial pressure of more than 25 mmHg with a normal pulmonary capillary wedge of less than 15 mmHg. It is classified as World Health Organization group 4 PH, and is the only type that can be surgically cured by pulmonary endarterectomy (PEA). This operation needs to be carried out by a team with strong expertise, from the diagnostic and decisional pathway to the operation itself. However, because the disease has a very heterogeneous phenotype in terms of anatomy, degree of PH and the lack of a standard patient profile, not all cases of CTEPH can be treated by PEA. As a result, PH-directed medical therapy traditionally used for the other types of PH has been proposed and is utilized in CTEPH patients. Since 2015, we have been witnessing the rebirth of balloon pulmonary angioplasty, a technique first performed in 2001 but has since fallen out fashion due to major complications. The refinement of such techniques has allowed its safe utilization as a salvage therapy in inoperable patients. In the present keynote lecture, we will describe these therapeutic approaches and results

Detection and Molecular Characterization of a Canine Norovirus

We identified a novel calicivirus in a pup with enteritis. The isolate was related genetically (90.1% aa identity in the capsid protein) to a lion norovirus strain

Relationships among porcine and human P[6] rotaviruses: Evidence that the different human P[6] lineages have originated from multiple interspecies transmission events

AbstractPorcine rotavirus strains (PoRVs) bearing human-like VP4 P[6] gene alleles were identified. Genetic characterization with either PCR genotyping or sequence analysis allowed to determine the VP7 specificity of the PoRVs as G3, G4, G5 and G9, and the VP6 as genogroup I, that is predictive of a subgroup I specificity. Sequence analysis of the VP8* trypsin-cleavage product of VP4 allowed PoRVs to be characterized further into genetic lineages within the P[6] genotype. Unexpectedly, the strains displayed significantly higher similarity (up to 94.6% and 92.5% at aa and nt level, respectively) to human M37-like P[6] strains (lineage I), serologically classifiable as P2A, or to the atypical Hungarian P[6] human strains (HRVs), designated as lineage V (up to 97.0% aa and 96.1% nt), than to the porcine P[6] strain Gottfried, lineage II (<85.1% aa and 82.2 nt), which is serologically classified as P2B. Interestingly, no P[6] PoRV resembling the original prototype porcine strain, Gottfried, was detected, while Japanase P[6] PoRV clustered with the atypical Japanase G1 human strain AU19. By analysis of the 10th and 11th genome segments, all the strains revealed a NSP4B genogroup (Wa-like) and a NSP5/6 gene of porcine origin. These findings strongly suggest interspecies transmission of rotavirus strains and/or genes, and may indicate the occurrence of at least 3 separate rotavirus transmission events between pigs and humans, providing convincing evidence that evolution of human rotaviruses is tightly intermingled with the evolution of animal rotaviruses

The anti-inflammatory cytokine interleukin-37 is an inhibitor of trained immunity.

Summary Trained immunity (TI) is a de facto innate immune memory program induced in monocytes/macrophages by exposure to pathogens or vaccines, which evolved as protection against infections. TI is characterized by immunometabolic changes and histone post-translational modifications, which enhance production of pro-inflammatory cytokines. As aberrant activation of TI is implicated in inflammatory diseases, tight regulation is critical; however, the mechanisms responsible for this modulation remain elusive. Interleukin-37 (IL-37) is an anti-inflammatory cytokine that curbs inflammation and modulates metabolic pathways. In this study, we show that administration of recombinant IL-37 abrogates the protective effects of TI in vivo, as revealed by reduced host pro-inflammatory responses and survival to disseminated candidiasis. Mechanistically, IL-37 reverses the immunometabolic changes and histone post-translational modifications characteristic of TI in monocytes, thus suppressing cytokine production in response to infection. IL-37 thereby emerges as an inhibitor of TI and as a potential therapeutic target in immune-mediated pathologies